These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10552941

  • 1. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.
    Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC, Schlossman R, Alyea EP, Takvorian T, Jallow H, Kuhlman C, Ritz J, Nadler LM, Gribben JG.
    Blood; 1999 Nov 15; 94(10):3325-33. PubMed ID: 10552941
    [Abstract] [Full Text] [Related]

  • 2. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.
    Freedman AS, Gribben JG, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Pandite L, Robertson MJ, Kroon M, Ritz J, Nadler LM.
    Blood; 1996 Oct 01; 88(7):2780-6. PubMed ID: 8839876
    [Abstract] [Full Text] [Related]

  • 3. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
    Freedman AS, Neuberg D, Gribben JG, Mauch P, Soiffer RJ, Fisher DC, Anderson KC, Andersen N, Schlossman R, Kroon M, Ritz J, Aster J, Nadler LM.
    J Clin Oncol; 1998 Jan 01; 16(1):13-8. PubMed ID: 9440717
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
    Brown JR, Feng Y, Gribben JG, Neuberg D, Fisher DC, Mauch P, Nadler LM, Freedman AS.
    Biol Blood Marrow Transplant; 2007 Sep 01; 13(9):1057-65. PubMed ID: 17697968
    [Abstract] [Full Text] [Related]

  • 5. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P, Cornillet P, Deconinck E, Tourani JM, Gardembas M, Delain M, Abgrall JF, Kootz C, Milpied N.
    Bone Marrow Transplant; 2000 Nov 01; 26(9):971-7. PubMed ID: 11100276
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T, Jedlicková K, Kriegová E, Jarosová M, Raida L, Faber E, Hubácek J, Vondráková J, Pikalová Z, Indrák K.
    Neoplasma; 2001 Nov 01; 48(6):501-5. PubMed ID: 11949845
    [Abstract] [Full Text] [Related]

  • 8. High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
    Cao TM, Horning S, Negrin RS, Hu WW, Johnston LJ, Taylor TL, Shizuru JA, Hoppe RT, Brown BW, Blume KG, Stockerl-Goldstein KE.
    Biol Blood Marrow Transplant; 2001 Nov 01; 7(5):294-301. PubMed ID: 11400952
    [Abstract] [Full Text] [Related]

  • 9. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
    Apostolidis J, Gupta RK, Grenzelias D, Johnson PW, Pappa VI, Summers KE, Salam A, Adams K, Norton AJ, Amess JA, Matthews J, Bradburn M, Lister TA, Rohatiner AZ.
    J Clin Oncol; 2000 Feb 01; 18(3):527-36. PubMed ID: 10653868
    [Abstract] [Full Text] [Related]

  • 10. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
    Mahé B, Milpied N, Mellerin MP, Moreau P, Morineau N, Vigier M, Harousseau JL.
    Bone Marrow Transplant; 2003 Mar 01; 31(6):467-73. PubMed ID: 12665842
    [Abstract] [Full Text] [Related]

  • 11. Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma.
    Arcaini L, Montanari F, Alessandrino EP, Tucci A, Brusamolino E, Gargantini L, Cairoli R, Bernasconi P, Passamonti F, Bonfichi M, Zoli V, Bottelli C, Calatroni S, Troletti D, Merli M, Pascutto C, Majolino I, Rossi G, Morra E, Lazzarino M.
    Ann Oncol; 2008 Jul 01; 19(7):1331-1335. PubMed ID: 18344536
    [Abstract] [Full Text] [Related]

  • 12. Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.
    Kasamon YL, Jones RJ, Gocke CD, Blackford AL, Seifter EJ, Davis-Sproul JM, Gore SD, Ambinder RF.
    Biol Blood Marrow Transplant; 2011 Mar 01; 17(3):365-73. PubMed ID: 20655387
    [Abstract] [Full Text] [Related]

  • 13. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
    Rohatiner AZ, Johnson PW, Price CG, Arnott SJ, Amess JA, Norton AJ, Dorey E, Adams K, Whelan JS, Matthews J.
    J Clin Oncol; 1994 Jun 01; 12(6):1177-84. PubMed ID: 8201380
    [Abstract] [Full Text] [Related]

  • 14. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
    Johnson PW, Price CG, Smith T, Cotter FE, Meerabux J, Rohatiner AZ, Young BD, Lister TA.
    J Clin Oncol; 1994 Apr 01; 12(4):798-805. PubMed ID: 8151322
    [Abstract] [Full Text] [Related]

  • 15. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre.
    Foran JM, Apostolidis J, Papamichael D, Norton AJ, Matthews J, Amess JA, Lister TA, Rohatiner AZ.
    Ann Oncol; 1998 Aug 01; 9(8):865-9. PubMed ID: 9789609
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
    Berglund A, Enblad G, Carlson K, Glimelius B, Hagberg H.
    Eur J Haematol; 2000 Jul 01; 65(1):17-22. PubMed ID: 10914935
    [Abstract] [Full Text] [Related]

  • 17. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
    González-Barca E, Fernández de Sevilla A, Domingo-Claros A, Romagosa V, Martín-Henao GA, De Sanjose S, Carmona M, Petit J, García J, Grañena A.
    Bone Marrow Transplant; 2000 Nov 01; 26(10):1051-6. PubMed ID: 11108302
    [Abstract] [Full Text] [Related]

  • 18. Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma.
    Rambaldi A, Carlotti E, Oldani E, Della Starza I, Baccarani M, Cortelazzo S, Lauria F, Arcaini L, Morra E, Pulsoni A, Rigacci L, Rupolo M, Zaja F, Zinzani PL, Barbui T, Foa R.
    Blood; 2005 May 01; 105(9):3428-33. PubMed ID: 15637137
    [Abstract] [Full Text] [Related]

  • 19. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
    Pappa VI, Wilkes S, Salam A, Young BD, Lister TA, Rohatiner AZ.
    Bone Marrow Transplant; 1998 Sep 01; 22(6):553-8. PubMed ID: 9758342
    [Abstract] [Full Text] [Related]

  • 20. Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma.
    Apostolidis J, Foran JM, Johnson PW, Norton A, Amess J, Matthews J, Bradburn M, Lister TA, Rohatiner AZ.
    J Clin Oncol; 1999 Jan 01; 17(1):216-21. PubMed ID: 10458236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.